Analysts expect Mirum Pharmaceuticals, Inc. to report revenue of 172.22 M for Q3 26, against a range of 159.52 M to 184.92 M. The most recent reported quarter, Q2 26, came in at 176.20 M, a 2.7% beat against the 171.65 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 90.38 M | 99.41 M | 111.58 M | 127.78 M | 133.01 M | 148.93 M | 159.90 M | 176.20 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 81.48 M | 106.14 M | 100.39 M | 115.41 M | 134.07 M | 143.96 M | 167.44 M | 180.82 M | 184.92 M | 186.72 M | 210.49 M | 219.31 M | 214.24 M | 253.90 M | 237.58 M | 266.67 M | ||||||||||
| Low Estimate | 72.86 M | 98.41 M | 86.44 M | 94.63 M | 113.97 M | 135.33 M | 142.28 M | 162.48 M | 159.52 M | 157.26 M | 183.38 M | 198.40 M | 196.86 M | 218.56 M | 209.82 M | 218.38 M | ||||||||||
| Consensus Estimate | 77.17 M | 102.27 M | 93.41 M | 105.02 M | 124.02 M | 139.65 M | 154.86 M | 171.65 M | 172.22 M | 171.99 M | 196.93 M | 208.85 M | 205.55 M | 236.23 M | 223.70 M | 242.53 M |
Analysts expect Mirum Pharmaceuticals, Inc. to report earnings per share of -0.51 for Q3 26, against a range of -0.56 to -0.46. The most recent reported quarter, Q2 26, came in at -1.06, a 35.9% miss against the -0.78 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.30 | -0.49 | -0.30 | -0.12 | 0.05 | -0.10 | -13.43 | -1.06 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.43 | -0.24 | -0.33 | -0.30 | -0.13 | 0.06 | -0.33 | -0.73 | -0.46 | -0.54 | -0.32 | -0.24 | 1.14 | 1.58 | -1.23 | 0.95 | ||||||||||
| Low Estimate | -0.51 | -0.26 | -0.35 | -0.32 | -0.15 | 0.06 | -0.37 | -0.83 | -0.56 | -0.60 | -0.36 | -0.26 | 1.06 | 1.40 | -1.49 | 0.87 | ||||||||||
| Consensus Estimate | -0.47 | -0.25 | -0.34 | -0.31 | -0.14 | 0.06 | -0.35 | -0.78 | -0.51 | -0.57 | -0.34 | -0.25 | 1.10 | 1.49 | -1.36 | 0.91 |
Pull Wall Street consensus for Mirum Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=MIRM&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "MIRM", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=MIRM&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();